Mascoma Wealth Management LLC Eli Lilly & CO Transaction History

Mascoma Wealth Management LLC

$400 Million
Q3 2024

A detailed history of Mascoma Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 750 shares of LLY stock, worth $587,377. This represents 0.17% of its overall portfolio holdings.

Number of Shares

750

Previous 798 6.02%

Holding current value

$587,377

Previous $722,000 8.03%

% of portfolio

0.17%

Previous 0.19%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $37,062 - $46,080	-48 Reduced 6.02%	750 $664,000
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $5,798 - $7,272	-8 Reduced 0.99%	798 $722,000
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $17,766 - $23,768	-30 Reduced 3.59%	806 $627,000
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $17,331 - $20,431	-33 Reduced 3.8%	836 $487,000
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $108,378 - $144,914	-309 Reduced 26.23%	869 $407,000
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $55,602 - $65,302	179 Added 17.92%	1,178 $404,000
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $50,223 - $62,415	214 Added 27.26%	999 $286,000
Q3 2021 Oct 06, 2021	BUY	$221.6 - $272.71 $173,956 - $214,077	785 New	785 $181,000
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $122,593 - $158,573	-679 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $111,573 - $144,436	679 New	679 $126,000
Q3 2019 Nov 21, 2019	SELL	$106.79 - $116.16 $67,170 - $73,064	-629 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $10,979 - $11,777	-134 Reduced 17.56%	629 $51,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $58,804 - $65,267	763	763 $65,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.

Account

Mascoma Wealth Management LLC Eli Lilly & CO Transaction History